Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
Is Elective Nodal Irradiation (ENI) Necessary For Patients With Thoracic Esophageal Squamous Cell Carcinoma Who Undergo Esophagectomy And With Pathological Stage Of T1-2,N+,M0 -- A Randomized Phase Ⅲ Trial
Sponsor: Affiliated Hospital of Jiangsu University
Listed as NCT01398449, this PHASE3 trial focuses on Esophageal Squamous Cell Carcinoma and remains ongoing. Sponsored by Affiliated Hospital of Jiangsu University, it has been updated 7 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Dec 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Dec 2018 [monthly]
Unknown Status PHASE3
▶ Show 2 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE3
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Affiliated Hospital of Jiangsu University
- Anhui Provincial Hospital
- First Affiliated Hospital of Wenzhou Medical University
- Fudan University
- Fujian Cancer Hospital
- Jiangsu Cancer Institute & Hospital
- RenJi Hospital
- Shanghai Chest Hospital
- Shanghai Pulmonary Hospital, Shanghai, China
- The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
- The First Affiliated Hospital of Anhui Medical University
- The First Affiliated Hospital of Soochow University
- Zhejiang Cancer Hospital
- Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .